NCT03417947View on ClinicalTrials.gov

Vitamin D Supplementation in Children With Sickle Cell Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Sickle Cell Disease
Interventions
DIETARY_SUPPLEMENT

Vitamin D bolus

One single oral liquid vitamin D3 supplement of 300 000 IU

DIETARY_SUPPLEMENT

Placebo

Placebo identical in taste and appearance to the vitamin D bolus

Trial Locations (1)

H3T 1C5

CHU Sainte-Justine, Montreal

Sponsors

Collaborators (1)

Euro-Pharm
All Listed Sponsors
collaborator

Euro-Pharm

UNKNOWN

lead

St. Justine's Hospital

OTHER